logo
light
search

LYFCX Holdings List NMFQS:LYFCX

Health | AlphaCentric Funds
$15.77
↓ $-0.24 (-1.50%)
Last Updated: Feb 11, 2026

AlphaCentric Life Sciences and Healthcare Fund Class C (LYFCX) is a Health fund with $1.60 Million in assets. The fund allocates 39.95% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.

The largest holding in the fund is UNITED THERAPEUT at 5.58% of total assets. This is followed by FIRST AM-TR OB-X (3.44%) and BIOCRYST PHARM (5.04%).

LYFCX Holdings

Name Weight Owned Change
UNITED THERAPEUT 5.58% - -
FIRST AM-TR OB-X 3.44% - -
BIOCRYST PHARM 5.04% - -
PFIZER INC 4.73% - -
HARMONY BIOSCIE 4.68% - -
PACIRA BIOSCIENC 4.06% - -
ARGENX SE - ADR 3.43% - -
GALAPAGOS NV-ADR 3.77% - -
MIRUM PHARMACEUT 2.64% - -
BEIGENE LTD-ADR 2.58% - -
MERCK CO 3.29% - -
NEUROCRINE BIOSC 3.38% - -
INDIVIOR PLC 2.85% - -
BIOMARIN PHARMAC 2.76% - -
SAREPTA THERAPEU 2.71% - -
DYNAVAX TECHNOLO 2.71% - -
GILEAD SCIENCES 7.87% - -
VERTEX PHARM 5.95% - -
ASTRAZENECA-ADR 5.31% - -
INSMED INC 4.14% - -
IONIS PHARMACEUT 3.95% - -
INCYTE CORP 3.72% - -
VERONA PHAR-ADR 2.93% - -

Asset Allocation

Bond 0.00%
Cash 3.33%
Non US Stock 17.65%
Not Classified 0.00%
Other 0.00%
US Stock 79.02%

Market Cap

AverageMarketCap 15244.55%
Giant 6.82%
Large 18.10%
Medium 23.31%
Micro 16.10%
Small 22.60%

Sector Weights

Cash and Equivalents 0.00%
Corporate 0.00%
Derivative 0.00%
Government 0.00%
Municipal 0.00%
Securitized 0.00%
Basic Materials 0.00%
Consumer Cyclical 0.00%
Financial Services 0.00%
Real Estate 0.00%
Consumer Defensive 0.00%
Healthcare 100.00%
Utilities 0.00%
Communication Services 0.00%
Energy 0.00%
Industrials 0.00%
Technology 0.00%

World Regions

Latin America 0.00%
North America 81.74%
Asia Developed 0.68%
Asia Emerging 0.00%
Australasia 0.00%
Japan 0.00%
Africa/Middle East 0.00%
Europe Developed 5.96%
Europe Emerging 0.00%
United Kingdom 11.62%